SCHEMBL6081395

SCHEMBL6081395

CCN(C(=O)OC(C)(C)C)c1ccc(NC(=O)c2c(-c3c(Cl)cccc3Cl)noc2C)cc1

nearest known ligand 0.72

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 13/20 0.72
PTGS2 P35354 6/20 0.63
TP53 P04637 1/20 0.56
MAPT P10636 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3637769 0.84 GHSR (1.00) GHSRPTGS2
SCHEMBL3635879 0.84 GHSR (0.79) GHSRPTGS2
SCHEMBL3636499 0.81 GHSR (1.00) GHSRPTGS2
SCHEMBL3636109 0.80 GHSR (0.79) GHSRPTGS2TP53MAPT
SCHEMBL3632135 0.80 GHSR (0.87) GHSRPTGS2
SCHEMBL3638189 0.79 GHSR (0.89) GHSRPTGS2
SCHEMBL3634973 0.79 GHSR (0.88) GHSRTP53MAPT
SCHEMBL3637872 0.75 GHSR (0.80) GHSRPTGS2
SCHEMBL3637758 0.75 GHSR (1.00) GHSR
SCHEMBL5158195 0.75 GHSR (1.00) GHSRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089398-A1 Isoxazole carboxamide derivatives as ghrelin receptor modulators NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089398-A1 Isoxazole carboxamide derivatives as ghrelin receptor modulators GPR119, GIPR, GLP1R GHSR 5/4885PTGS2 2925/4885TP53 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.